Defining the mode of action of cisplatin combined with NUC-1031, a phosphoramidate modification of gemcitabine
The combination of gemcitabine with platinum agents is a widely used chemotherapy regimen for a number of tumour types. Gemcitabine plus cisplatin remains the current therapeutic choice for biliary tract cancer. Gemcitabine is associated with multiple cellular drug resistance mechanisms and other li...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2024-12-01
|
| Series: | Translational Oncology |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S1936523324002419 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|